This week, Politico Pro Health convened a panel of experts from across the health care spectrum to discuss the realities of coordinating care and hospital realignment. The panel, a robust set of experts from the Federal Trade Commission, hospital systems and health care law engaged in a substantive discussion of efforts by hospitals nationwide to pursue mergers and realignments, and the challenges and outcomes providers face in these transactions.
This discussion echoed much of what the latest studies and reports of 21st century realignments show—that the misconceptions and stereotypes of monopolies & reduced competition and well as increased pricing power are, in fact, not correct. Patient benefits, improved efficiencies and cost savings from local examples were just some of the headlines from hospital systems living the reality of realignment today.
The following are key takeaways from yesterday’s discussion:
Understanding the state of the U.S. health system & focus on clinical integrated care
Martin Gaynor, who heads the Federal Trade Commission’s economic bureau, addressed the current state of mergers and realignments on a national scale saying, “The FTC’s role is to try and help markets work as well as they can to benefit consumers. There’s a lot of things going on in the health care sector– a lot of consolidation, alliances. People are searching for new forms of organizations and I think this is done to improve quality.”
Gaynor also discussed the Triple Aim (lower cost, better quality of care and better population health) as a driver in the health care system overall, and one main component of the pursuit of realignments. Hospitals are merging in an effort to achieve this Triple Aim for patients.
The view from local hospitals: popular sentiments on consolidation are wrong
All of the panelists discussed the importance of clinically integrated care, and the evolution of the health care system to more coordinated care models for patients. This transformation is of critical importance to all in the health system.
John Colmers, VP of Health Care Transformation and Strategic Planning for Johns Hopkins Medicine refuted the common misconceptions about hospital realignment, saying, “The view on consolidation is narrow minded and backwards. Hospitals are undergoing a fundamental set of changes.”
Colmers discussed the focus across health care on increased transparency and measuring outcomes, and pointed to efforts by Johns Hopkins to realign with 4 local Washington-area facilities. “This is about expansion of our services in ways that benefit the populations they serve,” he said. “We are working on clinical integration and have been able to extend the advantages of outstanding care in service areas distinct from us. Our thinking has evolved. I think the world is moving in that direction.”
Deborah Zastocki, President of Chilton Medical Center and Vice President of Atlantic Health System also spoke to the real effects of realignment she has experienced in recent years. Zastocki cited “a need for infrastructure bench strength, for access to capital” as drivers for the realignments her health system pursued – the need to merge to survive, and thrive.
And Zastocki points to proof positive the hospitals are thriving, with effects of the realignment including: clinically integrated care systems, enhanced service lines, expanded access through outpatient services, implementation of EHR systems and efforts to meet deadlines for critical national benchmarks.
“We now have rapid implementations of initiatives,” she said. “We are using much more ehealth now, our renowned stroke program has improved and expanded.”
Looking at cross-state mergers and realignments she has overseen, Zastocki said, “I have seen clear benefits to our community and patients. And we have seen operational efficiencies and lower costs. What we have seen of the past is one thing; what we see in the future is another thing. The types of things we can now do is game changing.”
A May report from the Altarum Institute addressed the pricing power misconception on a national scale, saying: “While analysts continue to express concern about the potential pricing power from provider consolidation there is, as yet, scant evidence of this.”
Sharis Pozen, a partner at Skadden, Arps, Slate, Meagher and Flom, who has also worked for the Department of Justice and FTC, was emphatic in her support of realignment as a means for better health care. “The vast majority [of realignments] are not raising prices, not eliminating competition,” she said. “You see these alignments- important alignments going on. Quality of care for patients is the goal, and hospitals align to achieve it. The efforts with clinical integration can only spur those alignments as well.”
The role of the FTC
Having the input of the FTC on a panel such as this was incredibly important, because Martin Gaynor was able to shed light on how and why the FTC assesses proposed mergers, and what factors drive their decisions. When asked about the decision on which proposed mergers to investigate, Gaynor said, “The vast majority we review, we close the matter because either we don’t feel it raises concerns or we have no strong evidence.”
Indeed the FTC’s numbers reflect that. From 2007-2011 of 333 mergers & acquisitions and realignments pursued, 111 were reported to the FTC and only 4 were challenged. Gaynor added, “When we pursue something it is before a merger has occurred. If we get involved post facto they [mergers] are hard to undo.”
And the criteria for an approved realignment? Gaynor says the FTC looks as whether the merged entity will be able to lower cost substantially and offer improved quality of care. “We look at whether a merger is necessary to provide consumer benefits,” he said.
Competition in health care & the consumer paradox
Gaynor, in looking at the issue of competition in the market, said mergers and realignments generally are not anticompetitive. This is supported by the FTI 2014 analysis which showed one of the many consumer benefits from realignments was more competitive health care markets.
Gaynor also addressed the impact of competition on consumers, saying, “We know there is substantial research that says where there is more competition prices are lower. At the end of the day higher prices come back and come out of consumers’ wallets. Prices go up, insurance rates go up, employer premiums up.”
In this discussion, Gaynor also said in some cases health insurance costs are going up for consumers, citing consistent wages (or improving wages) as driving down coverage. These sentiments hit at the core of the consumer paradox we are experiencing in health care today.
In sum, the panel addressed the many concurrent changes and trends occurring across health care and their role in the effort to coordinate care through realignment. With insights from the FTC and local hospital system, we see further evidence of realignment creating great benefits, better efficiencies and refuting the many misconceptions on pricing and competition. As all actors in the health care industry work towards Triple Aim goals, the implementation of clinical integrated care systems and critical benchmarks for care delivery, better understanding of the positive effects of realignment will be an important factor in a transformed U.S. health system.